[go: up one dir, main page]

PE20000423A1 - Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene - Google Patents

Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene

Info

Publication number
PE20000423A1
PE20000423A1 PE1999000296A PE00029699A PE20000423A1 PE 20000423 A1 PE20000423 A1 PE 20000423A1 PE 1999000296 A PE1999000296 A PE 1999000296A PE 00029699 A PE00029699 A PE 00029699A PE 20000423 A1 PE20000423 A1 PE 20000423A1
Authority
PE
Peru
Prior art keywords
cafiles
methylpropionic acid
pharmaceutical composition
composition containing
acid derivative
Prior art date
Application number
PE1999000296A
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Hideyuki Muranaka
Masaaki Sato
Masuo Akahane
Harunobu Mukaiyama
Akihito Hirabayashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PE20000423A1 publication Critical patent/PE20000423A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN DERIVADO DEL ACIDO 2-METILPROPIONICO DE FORMULA I, DONDE R1 ES H, ALQUILO, ARALQUILO; R2 ES H, ALQUILO, HALOGENO; A ES O, IMINO. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I TIENE EFECTOS ESTIMULANTES DE ß3-ADRENOCEPTORES Y PUEDE SER UTIL PARA LA PREVENCION O TRATAMIENTO DE LA OBESIDAD, HIPERGLICEMIA, ENFERMEDADES CAUSADAS POR LA HIPERMOTILIDAD INTESTINAL, POLAQUIURIA, INCONTINENCIA URINARIA, DEPRESION, ENFERMEDDES CAUSADAS POR CALCULOS BILIARES, HIPERMOTILIDAD DEL TRACTO BILIAR
PE1999000296A 1998-04-14 1999-04-12 Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene PE20000423A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14202898 1998-04-14

Publications (1)

Publication Number Publication Date
PE20000423A1 true PE20000423A1 (es) 2000-05-22

Family

ID=15305697

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000296A PE20000423A1 (es) 1998-04-14 1999-04-12 Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene

Country Status (19)

Country Link
US (2) US6696489B1 (es)
EP (1) EP1072583B1 (es)
JP (1) JP4212771B2 (es)
KR (1) KR100576131B1 (es)
AR (1) AR015761A1 (es)
AT (1) ATE275126T1 (es)
AU (1) AU768217C (es)
CA (1) CA2328348C (es)
CO (1) CO5021214A1 (es)
DE (1) DE69919860T2 (es)
ES (1) ES2228028T3 (es)
IL (1) IL138994A (es)
MY (1) MY122400A (es)
NO (1) NO20005164L (es)
NZ (1) NZ507486A (es)
PE (1) PE20000423A1 (es)
TW (1) TW581754B (es)
WO (1) WO1999052856A1 (es)
ZA (1) ZA200005589B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1146035T3 (da) * 1999-01-21 2006-03-27 Kissei Pharmaceutical Krystalpolymorfi af aminoethylphenoxyeddikesyrederivat
BR0316080A (pt) * 2002-11-07 2005-09-27 Astellas Pharma Inc Remédio para bexiga superativa compreendendo derivado de ácido acético anildo como o ingrediente ativo
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
AU2004212381B2 (en) * 2003-02-14 2008-08-21 Kissei Pharmaceutical Co., Ltd. Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
ITMI20061581A1 (it) 2006-08-04 2008-02-05 Univ Bari Ligandi del recettore beta-3 adrenergico e loro uso in terapia
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
EP0023385B1 (en) * 1979-06-16 1982-12-15 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
FR2750668B1 (fr) 1996-07-03 1998-11-20 Savard Franck Dispositif de tension et de guidage d'une chaine pour un changement de vitesses de velo
AU4320297A (en) * 1996-09-26 1998-04-17 Kissei Pharmaceutical Co. Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives
ID24062A (id) 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
PL341221A1 (en) * 1997-12-18 2001-03-26 Kissei Pharmaceutical Derivatives of phenylaminoalkyl carboxylic acid and pharmacological compositions containing them

Also Published As

Publication number Publication date
NO20005164L (no) 2000-12-12
US20030166719A1 (en) 2003-09-04
US6790865B2 (en) 2004-09-14
IL138994A0 (en) 2001-11-25
ES2228028T3 (es) 2005-04-01
NZ507486A (en) 2003-03-28
KR20010042683A (ko) 2001-05-25
CA2328348A1 (en) 1999-10-21
AU3166199A (en) 1999-11-01
TW581754B (en) 2004-04-01
DE69919860D1 (de) 2004-10-07
EP1072583A4 (en) 2001-12-05
AU768217C (en) 2005-04-21
IL138994A (en) 2004-02-19
AU768217B2 (en) 2003-12-04
ZA200005589B (en) 2002-01-11
NO20005164D0 (no) 2000-10-13
MY122400A (en) 2006-04-29
DE69919860T2 (de) 2005-08-25
WO1999052856A1 (en) 1999-10-21
ATE275126T1 (de) 2004-09-15
US6696489B1 (en) 2004-02-24
JP4212771B2 (ja) 2009-01-21
EP1072583A1 (en) 2001-01-31
EP1072583B1 (en) 2004-09-01
KR100576131B1 (ko) 2006-05-03
CA2328348C (en) 2009-03-03
CO5021214A1 (es) 2001-03-27
AR015761A1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
AR029600A1 (es) Un derivado del acido fenoxiacetico, una composicion farmaceutica que lo contiene y agente util para la prevencion de enfermedades, uso de un derivado del acido fenoxiacetico para la fabricacion de una composicion farmaceutica para los tratamientos de dichas enfermedades y el procedimiento de fabric
BR0211502A (pt) Derivados de ácido acético de indano e seu uso como agentes farmacêuticos, intermediários, e método de preparação
BR0009864A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto
ES2115096T3 (es) Derivados tetrazolicos de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
NO20015607D0 (no) Glukagonantagonister/inversagonister
EA200300316A1 (ru) Производные глюкопиранозилоксибензилбензола и содержащие их лекарственные композиции
BR0010555A (pt) Inibidores de neuraminidases
DK0736039T3 (da) Forbindelser med væksthormon-frigivende egenskaber
BRPI0412893A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de prevenção, tratamento ou melhora de doenças ou condições inflamatórias, ou doenças ou condições oftálmicas, de tratamento ou melhora de cáncer e para a produção de um composto
EP1072592A3 (en) 4-arylpiperidine derivatives for the treatment of pruritus
EA200200194A1 (ru) Антагонисты хемокинного рецептора и способы их применения
BR0316877A (pt) Derivados de aril-quinazolina/aril-2-amino-fenil metanona que promovem a liberação de hormÈnio da paratireóide
EP1891954A3 (en) Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
ES2143132T3 (es) Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion.
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
PE20000423A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene
CO5550443A2 (es) Derivados de 4-aril-2(1h)-quinazolina, su proceso de preparacion y una composicion farmaceutica que los contiene
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
PE20000131A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
PE20040668A1 (es) Nuevos derivados de piperidina
ES2051954T3 (es) 2-aminotiazoles substituidos.
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed